The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 44 (1) , 33-60
- https://doi.org/10.2165/00003088-200544010-00002
Abstract
Cytochrome P450s (CYPs) are an important family of enzymes in the metabolism of many therapeutic agents and endogenous metabolic reactions. The CYP3A subfamily is especially prominent in these metabolic activities. This review article focuses on how the factors of age and sex may influence the in vivo activity of human CYP3A. The functional activity of CYP3A varies based on issues such as interaction with one or more substrates and between individuals and/or localisation. For CYP3A substrates, intrinsic clearance is the component of total clearance that is contributed by the enzymes. Depending on the route of administration and the contribution of hepatic blood flow to overall clearance, sensitivities to changes in CYP3A activities may differ. Additionally, age may influence the hepatic blood flow and, in turn, affect CYP3A activity. A review of the literature regarding age influences on the clearance of CYP3A substrates does suggest that age can affect the clearance of certain CYP3A substrates. CYP3A is responsible for a large number of endogenous metabolic reactions involving steroid hormones, and enzyme activity has been reported to be induced and/or inhibited in the presence of some sex steroids. Based on published studies for most CYP3A substrates, sex does not appear to influence clearance; however, with certain substrates significant sex-related differences are found. In such cases, women primarily have higher clearance than men.Keywords
This publication has 188 references indexed in Scilit:
- Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with RitonavirThe Journal of Clinical Pharmacology, 1998
- Effect of Age and Gender on Pharmacokinetics of Atorvastatin in HumansThe Journal of Clinical Pharmacology, 1996
- Geographical/Interracial Differences in Polymorphic Drug OxidationClinical Pharmacokinetics, 1995
- Clarithromycin Pharmacokinetics in Healthy Young and Elderly VolunteersThe Journal of Clinical Pharmacology, 1992
- Influence of Age on the Pharmacokinetics of AlfentanilClinical Pharmacokinetics, 1990
- Pharmacokinetics of Buspirone in Elderly SubjectsThe Journal of Clinical Pharmacology, 1989
- Effects of Age, Gender and Oral Contraceptives on Intramuscular Midazolam PharmacokineticsThe Journal of Clinical Pharmacology, 1988
- No Evidence of a Genetic Polymorphism in the Oxidative Metabolism of MidazolamClinical Pharmacokinetics, 1988
- Pharmacokinetics and Blood Pressure Effects of Felodipine in Elderly Hypertensive PatientsClinical Pharmacokinetics, 1988
- Drug Disposition in Old AgeNew England Journal of Medicine, 1982